Navigation Links
New Research May Encourage Smokers to Jump-Start Their New Year's Resolution to Quit Smoking
Date:12/8/2008

t over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R) and NicoDerm(R)CQ(R), and Commit(R), as well as many medicine cabinet staples -- alli(R), Aquafresh(R), Sensodyne(R), and TUMS(R) -- which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.

    (1) Survey of 808 adult smokers interested in quitting conducted by
        GlaxoSmithKline Consumer Healthcare in October 2006.
    (2) Shiffman S, Sweeney CT, Ferguson S, et al. Adherence with Nicotine
        Patch Dosing and Treatment Efficacy: Secondary Analysis of a 10-Week
        Randomized, Double-Blind, Placebo-Controlled Clinical Trial of
        Over-the-Counter Patch in Adult Smokers.
    (3) Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine
        replacement therapy for smoking cessation. Cochrane Database of
        Systematic Reviews. 1996, Issue 3.
    (4) Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and
        Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD:
        U.S. Department of Health and Human Services. Public Health Service.
        May 2008.
    (5) GSK Data on file.

     Contacts:          Mark Polisky, GolinHarris
                        312-729-4417
                        mpolisky@golinharris.com

                        Jennifer May, GlaxoSmithKline
                        Consumer Healthcare
                        412-200-3729
                        '/>"/>
SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Research on the effects of stem cell source and patient age on transplantation outcomes
2. Research highlights new approaches to prevent blood clots
3. 50 years of hairy-cell leukemia research to be observed
4. Event Honoring Bill Gates Raises Over $1.5 Million for Sustainable Agriculture Research at The Hebrew University of Jerusalem
5. New Research Reports on Interventions that May Alter the Course of Epilepsy Diagnosis and Management
6. Researchers & Department of Defense Question Multiple Vaccine Administration
7. Researchers gain new insight on wonder of cell division
8. HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective
9. Jefferson researcher awarded NIH grant
10. Researcher develops screening tool to identify patients with prediabetes
11. Partnership for Peak Healthcare Performance Research Shows Consumers Lack Involvement in Managing Their Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... MD (PRWEB) , ... August 28, 2015 , ... As ... system from Merz, received FDA clearance for results that last for two years, ... is exciting news for patients who are looking for a long-lasting, effective solution for ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... abuse, or those who might personally be struggling with chemical dependency, may be ... from Best Drug Rehabilitation, a results-driven holistic treatment center for addiction located in ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima Technologies, Inc., the maker ... data center assets and audio-video devices, recently released Visio Stencils for the following ... ProLiant Gen9, EMC VNX Series , Super Micro Computer SuperStorage, Hitachi Data Systems ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Nashville ... military veterans leading in business. Mr. Troy Mizell, Chairman of the Board ... Nashville Business Journal's 2015 Veterans Awards will recognize Nashville military veterans who, through ...
(Date:8/28/2015)... Arizona (PRWEB) , ... August 28, 2015 , ... ... and increased patient loyalty at a low cost. Personalized with practice contact information ... and existing patients. Dental offices can also incorporate Calendars into seasonal mailings, thank ...
Breaking Medicine News(10 mins):Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2
... Pa. , Jan. 27 CONNEXION Healthcare (CXHC) ... as Executive Vice President, Client Services. In this role, ... of CXHC, including its Clinical CONNEXION and Publication CONNEXION business ... of pharmaceutical marketing and sales experience.  Most recently, Rob served ...
... , DESTIN, Fla. , Jan. 27 Concordis ... today that Dr. K. Barton Farris has been appointed ... of this committee Dr. Farris will advise the company in its ... Trent Sommerville , Chairman and CEO of Concordis Group stated, "I ...
... ... , Jan. 27 Haiti is the poorest ... and other international relief agencies are there, they are mostly stationed where ... ( www.oiww.org ), located just outside Jacmel in the Southern Province, survived ...
... for Molecular Medicine and Therapeutics have uncovered a key ... disease, and identified a possible treatment for the disease. ... today and will appear in the January 28 edition ... is an inherited degenerative brain disease that causes cognitive ...
... PORTLAND, Ore.-- Adults with chronic rhinosinusitis a debilitating inflammation ... keeps coming back report significantly improved quality of ... a new study led by Oregon Health & Science ... issue of Otolaryngology Head and Neck Surgery ...
... ... supports on BetterBraces.com. , ... Diego, CA (PRWEB) January 22, 2010 -- DonJoy Velocity ankle braces were the ... total sales of Velocity ankle braces were double that of other ankle supports sold on ...
Cached Medicine News:Health News:Robert Naticchia Joins CONNEXION Healthcare as Executive Vice President, Client Services 2Health News:Concordis Group, Inc. Appoints Head of Physician Advisory Council 2Health News:Orphans International Worldwide Haiti Near Jacmel to Grow After Earthquake 2Health News:Orphans International Worldwide Haiti Near Jacmel to Grow After Earthquake 3Health News:Orphans International Worldwide Haiti Near Jacmel to Grow After Earthquake 4Health News:Orphans International Worldwide Haiti Near Jacmel to Grow After Earthquake 5Health News:Discovery of mechanism in brain cell injury in Huntington's offers new treatment approaches 2Health News:Surgery helps chronic sinusitis sufferers get relief 2Health News:DonJoy Velocity Ankle Brace is the Best Selling Ankle Brace in 2009 2
(Date:8/28/2015)... 2015  Delays in the launch and execution ... the decision-making process, resulting in missed opportunities and ... biopharmaceutical companies to develop a tactical approach to ... and more meaningful insights. According ... three-quarters of benchmarked study participants use review cycle ...
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "Investigation ... to their offering. Originally discovered by ... Yoshitomi Pharmaceutical Industries, Ltd) as an inflammatory drug, ... Senju Pharmaceutical Co., Ltd under the trade name ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Tobramycin ... Tobramycin is a traditional antibiotic whose eye drop and ... treatment of potential infection or inflammation caused by eye ... are able to produce tobramycin, among which ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2
... N.Y., Oct. 25, 2011 Misonix, Inc. (NASDAQ: ... that designs, manufactures and markets innovative therapeutic ultrasonic ... surgery, neurosurgery, laparoscopic surgery, and other surgical and ... the BoneScalpel™ Ultrasonic Bone Cutting System at the ...
... HIGHLIGHTS:2011 Results (all percentages are to comparable periods in 2010) ... to $626 million. Q3 sales grew organically by 4% with ... 4% and 2%, respectively.  Recently completed acquisitions contributed an additional ... additional 5% to reported sales growth in Q3. ...
Cached Medicine Technology:Misonix Exhibits BoneScalpel™ at the International Meeting on Advanced Spine Techniques 2Misonix Exhibits BoneScalpel™ at the International Meeting on Advanced Spine Techniques 3Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 2Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 3Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 4Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 5Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 6Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 7Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 8Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 9Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 10Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 11Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 12Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 13
... RNA Mini Kit allows purification ... cell-free fluid samples. Examples of ... be isolated with this kit ... to, RNA from hepatitis A, ...
The Mago® Plus Automated EIA Analyzer is a fully automated, integrated ELISA system. Together, with immunosimplicity® reagents, the Mago® Plus provides a flexible, integrated solution ...
... computer-enhanced microplate reader with a ... flexible and rapid photometric analysis. ... and reliable photometric measurement of ... shaking before reading) and can ...
The Rapidpoint 400/405 instrument is a point-of-care blood gas analyzer that's fast, easy to operate and reliable....
Medicine Products: